About The Study: In 2023, reported breast and colorectal cancer screening rebounded from COVID-19 pandemic–related declines and surpassed pre-pandemic estimates. These findings are encouraging given larger-than-expected declines in early-stage breast and colorectal cancer diagnoses in 2020 and increases in distant-stage breast cancer diagnoses through 2021. Cervical cancer screening rates remained below pre-pandemic levels, a troubling trend as early-stage diagnoses continued to decrease in 2021. The persistent decline may in part reflect longer-term declines in patient knowledge and clinician recommendation of cervical cancer screening.
Corresponding Author: To contact the corresponding author, Jessica Star, MA, MPH, email Jessica.star@cancer.org .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.0902)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.0902?guestAccessKey=8f0ea9de-3afc-4fa8-bd34-c3bc01f449b6&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_cotent=tfl&utm_term=030525
JAMA